Most popular biological drug targets 2019 vs. 2018

ACROBiosystems is a leading manufacturer of recombinant proteins, critical reagents and kits to support the development of targeted therapeutics. Our catalog includes a comprehensive list of disease-associated biomarkers and drug targets from human and other common species, which are widely used in targets discovery, immunization, screening, preclinical and clinical stages.
So far, ACROBiosystems has been working with more than 3500 pharmaceutical and biotech companies working on biological drug discovery and development globally. Here we analyze our top selling targets in 2018 and 2019 to help you learn the trend from this particular perspective.
The quality of the proteins below have been verified by multiple assays at ACROBiosystems and the protocols can be offered for free.
Hot targets of global ranking
| TOP10 Targets in 2018 | TOP10 Targets in 2019 |
| PD-1 | CD19 2 |
| PD-L1 | BCMA 2 |
| CD19 | PD-L1 1 |
| BCMA | PD-1 3 |
| Her2 | Her2 1 |
| CD47 | CD3 epsilon 4 |
| TIGIT | CD3E & CD3D 4 |
| LAG-3 | Siglec-15 392 |
| CD3 epsilon | VEGF165 9 |
| CD3E & CD3D | BAFFR 10 |
Check Key Product Lines and New Product Launch
Popular Articles
Related Recommendations
Popular Events
Beyond Bispecifics: How Multispecific Antibodies Are Breaking the Efficacy Ceiling2026-08-10Page Views:79
Autoimmune Disease 3.0: Biomarkers Driving the Future of Precision Drug Development2026-08-06Page Views:85
Application-Oriented Functional Cell Lines | Case Study Series2026-08-03Page Views:110
AI-Assisted Bispecific Antibody Development: From Target Pairing Prediction to Experimental Validation2026-07-31Page Views:138
The Brain's Fountain of Youth: How Modern Neuroscience Is Decoding Healthy Brain Aging2026-07-31Page Views:83





























